Spyre Therapeutics, Inc. (SYRE)
33.56
-0.40
(-1.18%)
USD |
NASDAQ |
Feb 10, 16:00
33.59
+0.03
(+0.09%)
After-Hours: 20:00
Spyre Therapeutics Total Liabilities (Quarterly) : 49.50M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 2.799B |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.60M |
| Shareholders Equity (Quarterly) | 455.10M |
| Current Ratio | 10.90 |